|
⚲
|
| Synergy Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 001347613 |
| Sale | 2009-02-12 ($18.2 M Offered, $15.9 M Sold) |
| Fund | |
| Phone | 2122970020 |
| Address | 420 Lexington Avenue New York, 10170 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Melvin Spigelman | |
| Bernard Denoyer | |
| Kunwar Shailubhai | |
| John Brancaccio | |
| Thomas Adams | |
| Gary Jacob | |
| Gabriele Cerrone |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Potter Charles
✚
|
0.0 | |
|
Potter Tristan
✚
|
0.0 | |
|
Potti Ram
✚
|
0.0 | |
|
Potti Sunil
✚
|
0.0 | |
|
Powell Benny R.
✚
|
0.0 | |
|
Rennyson David J
✚
|
0.0 | |
|
Renton Highland Manor LLC
✚
|
0.0 | |
|
Renzi Anthony N.
✚
|
0.0 | |
|
Replay Resources LLC
✚
|
0.0 | |
|
Potranco LP Investors 2021 LLC
✚
|
0.0 |